Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cancer vaccination.

M Del Vecchio1, G Parmiani

  • 1Unit of Immunotherapy of Human Tumours, Istituto Nazionale per lo Studio e la Cura dei Tumori, Milan, Italy.

Forum (Genoa, Italy)
|September 30, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Randomized, double-blind, phase III LEAP-003 study of first-line lenvatinib plus pembrolizumab versus placebo plus pembrolizumab for unresectable or metastatic melanoma.

Annals of oncology : official journal of the European Society for Medical Oncology·2025
Same author

Guidelines for the diagnosis and treatment of cutaneous squamous cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

ESMO open·2024
Same author

Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

ESMO open·2023
Same author

The web of laughter: frontal and limbic projections of the anterior cingulate cortex revealed by cortico-cortical evoked potential from sites eliciting laughter.

Philosophical transactions of the Royal Society of London. Series B, Biological sciences·2022
Same author

Simultaneous stereo-EEG and high-density scalp EEG recordings to study the effects of intracerebral stimulation parameters.

Brain stimulation·2022
Same author

Immune checkpoint inhibitor associated vitiligo and its impact on survival in patients with metastatic melanoma: an Italian Melanoma Intergroup study.

ESMO open·2021
Same journal

The basis of allograft acceptance.

Forum (Genoa, Italy)·2011
Same journal

Recurrent liver disease after liver transplantation.

Forum (Genoa, Italy)·2011
Same journal

Integrated treatments for non-small cell lung cancer.

Forum (Genoa, Italy)·2006
Same journal

Gastrointestinal tumors.

Forum (Genoa, Italy)·2006
Same journal

Primary and metastatic brain tumors.

Forum (Genoa, Italy)·2006
Same journal

Impact of integrated treatments on patient management in solid tumors: from diagnosis to palliative care.

Forum (Genoa, Italy)·2006
See all related articles

Cancer vaccines harness the immune system to fight tumors by targeting tumor-associated antigens. Advances in understanding antigen presentation and immunogenicity are revolutionizing cancer vaccine development and clinical applications.

Area of Science:

  • Oncology
  • Immunology
  • Vaccinology

Background:

  • Solid tumor growth relies on factors like angiogenesis, genetic mutations, and immune evasion.
  • Cancer vaccines aim to stimulate a patient's immune response against tumor-associated antigens.
  • Historical efforts to treat cancer with vaccines date back to early infectious disease vaccines.

Purpose of the Study:

  • To review the biological basis for cancer vaccine development.
  • To discuss the clinical applications of various tumor vaccines.
  • To highlight recent advancements in cancer vaccine technology.

Main Methods:

  • Review of scientific literature on tumor immunology and vaccine development.
  • Analysis of tumor-associated antigens and their immunogenic properties.

Related Experiment Videos

  • Examination of mechanisms of tumor antigen presentation and immune stimulation.

    • Main Results:

    • Identification of tumor-associated antigens enables elicitation of humoral and cell-mediated immunity.
    • Progress in defining immunogenic epitopes and augmenting immunogenicity has advanced the field.
    • New insights into tumor antigen presentation have revolutionized vaccine strategies.

    Conclusions:

    • Cancer vaccines represent a promising therapeutic strategy by activating host immunity against tumors.
    • Recent scientific progress has transformed cancer vaccines from non-specific approaches to targeted therapies.
    • Further research into vaccine development and clinical application holds significant potential for cancer treatment.